phenytoin has been researched along with Alloxan Diabetes in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sarges, R | 1 |
| Schnur, RC | 1 |
| Belletire, JL | 1 |
| Peterson, MJ | 1 |
| Shingalapur, RV | 1 |
| Hosamani, KM | 1 |
| Keri, RS | 1 |
| Hugar, MH | 1 |
| Sheir, MM | 1 |
| Nasra, MMA | 1 |
| Abdallah, OY | 1 |
| Alaraj, M | 3 |
| Saadh, MJ | 3 |
| Alafnan, A | 3 |
| Chan, FC | 1 |
| Kennedy, C | 1 |
| Hanson, RP | 1 |
| O'Sullivan, B | 1 |
| Kelly, J | 1 |
| Bouchier-Hayes, D | 1 |
| Kim, YC | 1 |
| Kang, HE | 1 |
| Lee, MG | 1 |
| Norling, LL | 1 |
| Colca, JR | 1 |
| Brooks, CL | 1 |
| Kloepper, RF | 1 |
| McDaniel, ML | 1 |
| Landt, M | 1 |
| Espósito Avella, M | 1 |
| Martínez, M | 1 |
| Vergara, G | 1 |
| Boquist, L | 1 |
| McNamara, PJ | 1 |
| Blouin, RA | 1 |
| Brazzell, RK | 1 |
| Esposito-Avella, M | 1 |
| Mennear, JH | 2 |
| Gossel, TA | 1 |
12 other studies available for phenytoin and Alloxan Diabetes
| Article | Year |
|---|---|
Spiro hydantoin aldose reductase inhibitors.
Topics: Aldehyde Reductase; Animals; Cattle; Diabetes Mellitus, Experimental; Hydantoins; Indicators and Rea | 1988 |
Derivatives of benzimidazole pharmacophore: synthesis, anticonvulsant, antidiabetic and DNA cleavage studies.
Topics: Animals; Anticonvulsants; Benzimidazoles; Diabetes Mellitus, Experimental; DNA Cleavage; DNA, Bacter | 2010 |
Phenytoin-loaded bioactive nanoparticles for the treatment of diabetic pressure ulcers: formulation and in vitro/in vivo evaluation.
Topics: Animals; Chitosan; Collagen; Diabetes Mellitus, Experimental; Nanoparticles; Phenytoin; Pressure Ulc | 2022 |
Insulin potentiates the anticonvulsive activity of phenytoin against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Disease Models, Animal; Electroshock; Ins | 2022 |
Insulin potentiates the anticonvulsive activity of phenytoin against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Disease Models, Animal; Electroshock; Ins | 2022 |
Insulin potentiates the anticonvulsive activity of phenytoin against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Disease Models, Animal; Electroshock; Ins | 2022 |
Insulin potentiates the anticonvulsive activity of phenytoin against maximal electroshock-induced seizures in mice.
Topics: Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Disease Models, Animal; Electroshock; Ins | 2022 |
Topical diphenylhydantoin sodium can improve healing in a diabetic incisional animal wound model.
Topics: Animals; Collagen; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Evaluation, Preclin | 2007 |
Pharmacokinetics of phenytoin and its metabolite, 4'-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin.
Topics: Administration, Oral; Alloxan; Animals; Anticonvulsants; Area Under Curve; Blood Proteins; Diabetes | 2008 |
Specificity of inhibition of calcium- and calmodulin-dependent protein kinase by alloxan.
Topics: Alloxan; Animals; Brain; Cell Membrane; Diabetes Mellitus, Experimental; Islets of Langerhans; Kinet | 1984 |
[Plasma and pancreatic levels of diphenylhydantoin and their relation to protection from chemical diabetes induced alloxan in mice].
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Islets of Langerhans; Male; Mice; Pancreas; Pheny | 1981 |
Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
Topics: Acetazolamide; Alloxan; Animals; Bicarbonates; Blood Glucose; Deoxy Sugars; Diabetes Mellitus, Exper | 1979 |
The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
Topics: Adult; Aldehyde Reductase; Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus; Diabetes Melli | 1988 |
Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.
Topics: Alloxan; Animals; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Hyp | 1973 |
Inhibitory effect of diphenylhydantoin on the diabetogenic action of alloxan in the mouse.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glutathione; Injections, Intraperi | 1972 |